Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.
about
Scavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyTrabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironmentThe Danish Melanoma DatabaseClinical and biological determinants of melanoma progression: Should all be considered for clinical management?The Fate of the Tumor in the Hands of Microenvironment: Role of TAMs and mTOR Pathway.Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapyDifferential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancerTumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancerThe density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer.Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients.The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patientsHead and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrencesThe distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancerTumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.Extracellular mycobacterial DnaK polarizes macrophages to the M2-like phenotypeThe clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastomaDifference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors.Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma.CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth.BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor GrowthNF-κB Regulation of c-FLIP Promotes TNFα-Mediated RAF Inhibitor Resistance in MelanomaObjective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206).The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer.Triggering Receptor Expressed on Myeloid Cells in Cutaneous MelanomaA subset of human uterine endometrial macrophages is alternatively activated.Trial watch: Prognostic and predictive value of the immune infiltrate in cancerTumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinomaMolecular targeting of liposomal nanoparticles to tumor microenvironment.Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancerMelanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature.Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma.Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancerExpression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.CD163 and c-Met expression in the lymph node and the correlations between elevated levels of serum free light chain and the different clinicopathological parameters of advanced classical Hodgkin's lymphoma.The role of the immune response in merkel cell carcinoma.
P2860
Q26799114-C12A5281-9FD6-48E7-9173-8BFC0EA50880Q26851658-5FC48F59-FE64-4DC8-AE7C-C918B2FDE8B3Q28073693-EAAA2841-2966-4BCC-89C3-BA90A046E56AQ30252150-5080D543-E72C-4FDD-AA46-DB9F64FC4B69Q33364555-8416F7E2-F98F-4320-ACBF-BA400AA602C1Q33416940-3A8E4AB3-4F51-4CBA-85BF-D3AE05654C15Q33576409-B22D2850-F276-4B93-B401-830EC7A00112Q33644262-A011EE51-BAC1-4BD5-82CC-2F3C9687A67DQ33737094-59222B51-C0D7-4988-8E9E-15A758B6F36FQ33816055-F7D953D5-8A1D-4E85-92D4-9A3E116A180FQ33982331-4D12CB51-3939-4217-AB57-24D20CD8C64AQ34348172-E2963769-A07A-4820-9FEA-EF3B56F0E232Q34354547-B3BAC6B8-4189-42A0-8248-6B73A015215CQ34450525-58F0E753-C40A-45C4-826D-C9FAE5D27BD1Q34543033-2F941379-E14B-4613-B4E8-59B7D7D82FD8Q34566120-B0F81A20-9926-4CFB-AE8F-FC61EEE5B354Q34652179-49AEFDB2-1898-4B83-A0BA-753D3371224BQ34736639-0DCD1378-15EE-48C7-BB44-B442787FC7B1Q34998148-8F1A08F2-CFAB-4D2E-8199-69A473027092Q35118187-C9E6BD32-B38F-4D3D-A37F-D005FCE55EEFQ35205613-F944BA06-F78D-4909-BC4D-8037EF3D5630Q35251663-84240846-3B85-4261-9429-39A5C16D0ADAQ35738534-F2DAC103-4778-4DA2-A325-A9DCFDB41DBFQ35866890-8D43A669-F485-4EF1-96EB-318DAFF584ADQ35979023-F280BA40-A7EC-4277-887D-488BF6AD98AEQ36051547-06DDBBA5-24E1-46AD-B483-9A7A0523A0D7Q36098663-026890CA-85B4-4403-8441-4AC6BD77BC12Q36225443-7253FC1E-882A-4AAC-B2D4-0F129E5B1B28Q36309943-DAF60C3E-F914-44A7-B3DB-E0E952F58AA6Q36456483-C0B3061B-0D45-401F-AC92-3736CC082D63Q36466730-9DA4703A-9837-4C47-B436-675FB9150C5AQ36500108-D8CD86C1-9C16-4B91-8F95-68BA928FAFF9Q36568222-04CD9FF4-1DC5-4A7C-AC0B-39E344C183D0Q36738000-F68D526E-A14A-4FA8-9005-363B5DBF9B2BQ36783370-D7302F2A-9954-4FB7-964F-FB9593F6C8A2Q36896309-F1ABC224-B0D6-4A60-81D1-FE24904871F9Q36943867-623493E0-3067-47D3-902F-EF1C7599966AQ36946741-16E2C6C6-22E8-47FE-990F-B5A61310230FQ36973329-BC0E8B25-37B3-40C6-9492-680D887A1EEAQ37061729-FD882CAA-91E4-4896-B0FF-D79293CA7B90
P2860
Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Macrophage markers in serum an ...... on Cancer stage I/II melanoma.
@en
Macrophage markers in serum an ...... on Cancer stage I/II melanoma.
@nl
type
label
Macrophage markers in serum an ...... on Cancer stage I/II melanoma.
@en
Macrophage markers in serum an ...... on Cancer stage I/II melanoma.
@nl
prefLabel
Macrophage markers in serum an ...... on Cancer stage I/II melanoma.
@en
Macrophage markers in serum an ...... on Cancer stage I/II melanoma.
@nl
P2093
P50
P356
P1476
Macrophage markers in serum an ...... on Cancer stage I/II melanoma
@en
P2093
Henrik Schmidt
Ib Jarle Christensen
Maciej Bogdan Maniecki
Pia Sjoegren
Trine O Jensen
P304
P356
10.1200/JCO.2008.19.9919
P407
P577
2009-06-15T00:00:00Z